Advertisements


AstraZeneca"s Lumoxiti Gets FDA Nod for Hairy Cell Leukemia

Zacks.....»»

Category: topSource: redinewsSep 14th, 2018

AstraZeneca Receives FDA Approval For Rare B-Cell Lymphoma Drug Lumoxiti

AstraZeneca Receives FDA Approval For Rare B-Cell Lymphoma Drug Lumoxiti.....»»

Category: topSource: seekingalphaSep 18th, 2018

Roth Capital remains bullish on Stemline after AstraZeneca"s Lumoxiti approved

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 14th, 2018

AstraZeneca says FDA approves LUMOXITI for certain patients

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 13th, 2018

FDA grants approval of HCL treatment Lumoxiti to AstraZeneca

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 13th, 2018

Johns Hopkins All Children"s becomes first Florida pediatric hospital to have unique leukemia therapy

Johns Hopkins All Children’s Hospital is now the first pediatric hospital in Florida offering a cutting-edge cellular immunotherapy for advanced leukemia in children and young adults. It will be offering CAR-T Cell Gene Therapy for leukemia. Chimer.....»»

Category: topSource: bizjournalsAug 30th, 2018

Novartis" CAR-T Therapy Kymriah Gets Approval in Europe

Novartis (NVS) gets EC approval for CAR-T therapy, Kymriah, for the treatment of pediatric and young adult patients up to 25 years of age with B-cell acute lymphoblastic leukemia. Novartis AG NVS announced that the European Commiss.....»»

Category: worldSource: nytAug 27th, 2018

AstraZeneca"s Tagrisso Wins EU Nod for First-Line Lung Cancer

AstraZeneca's (AZN) Tagrisso gets an EU nod for first-line treatment of advanced or metastatic non-small cell lung cancer in patients with epidermal growth factor receptor (EGFR) m.....»»

Category: personnelSource: nytJun 11th, 2018

The future of 5G mobile data could hinge on a battle over utility pole fees

How much should AT&T and Verizon pay to put up 5G cell sites? A proposed FCC rule could set new limits......»»

Category: topSource: washpost11 hr. 25 min. ago

AstraZeneca says European Commission grants marketing authorization for Imfinzi

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall11 hr. 55 min. ago

November 16th Options Now Available For AstraZeneca (AZN)

Stock Options Channel.....»»

Category: topSource: redinews14 hr. 40 min. ago

AstraZeneca says Farxiga reduced heart risks in Phase III DECLARE-TIMI 58 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall18 hr. 40 min. ago

AstraZeneca CEO warns of medicine shortages following Brexit, Reuters reports

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 23rd, 2018

AstraZeneca CEO warns of medicine shortages after Brexit: Sunday Times

Britain could see widespread medicine shortages if there is no deal to prevent friction at the border with the European Union after Brexit, the AstraZeneca chief executive told the Sunday Times......»»

Category: topSource: reutersSep 23rd, 2018

AstraZeneca ceo warns of medicine shortages after Brexit: Sunday Times

Britain could see widespread medicine shortages if there is no deal to prevent friction at the border with the European Union after Brexit, the AstraZeneca chief executive told the Sunday Times......»»

Category: topSource: reutersSep 22nd, 2018

Your Daily Pharma Scoop: Viking Zooms, AstraZeneca Positive

Your Daily Pharma Scoop: Viking Zooms, AstraZeneca Positive.....»»

Category: topSource: seekingalphaSep 21st, 2018

A startup that wants to regenerate human hearts and brains just announced a new chief financial officer — and it could mean an IPO in 2019

Reuters BlueRock Therapeutics, a biotech company looking to create cell and gene therapies in the field of regenerative medicine, .....»»

Category: topSource: businessinsiderSep 21st, 2018

Brainstorm Health: Biden Cancer Summit, Mistreating Obesity, AstraZeneca in China

Brainstorm Health: Biden Cancer Summit, Mistreating Obesity, AstraZeneca in China.....»»

Category: europeSource: fortuneSep 20th, 2018

China makers trialing new solar cell technologies

China-based makers are keen on trialing new technologies, mainly PERC (passivated emitter and rear cell) TOPcon (tunnel oxide pasivated contact), N-type TOPcon and HIT (herterojunction with intrinsic thin layer), according to industry sources......»»

Category: topSource: digitimesSep 20th, 2018

Next Year, Half of All Calls to Cell Phones Will Be Scams—And There’s Nothing We Can Do

You're not imagining it: Scammers are increasing.....»»

Category: europeSource: fortuneSep 20th, 2018

More solar cell makers reportedly want to join URE

While United Ren.....»»

Category: topSource: digitimesSep 19th, 2018